STEM CELL PLASTICITY: REGENERATION OF FUNCTIONAL MYOCARDIUM FROM BONE MARROW STEM CELLS (BMSC).

S T. Ildstad,Y Huang,B Dawn,Y Guo,A Rezazadeh,A B. Stein,S D. Prabhu,Y Gu,G Hunt,J Varma,R Bolli

DOI: https://doi.org/10.1097/00007890-200407271-00430

2004-01-01

Transplantation

Abstract:O417 Aims: Bone marrow stem cells (BMSC) have been demonstrated to have the capacity to repair damaged neural, cardiac, and skeletal tissue under selected conditions. As such, BMSC offer great promise for regenerative medicine. However, functional assessment of outcomes has been limited, and it remains controversial whether significant functional repair can be achieved. Methods: In the present studies we evaluated whether treatment of mice with hematopoietic growth factors to mobilize BMSC would enhance functional repair after myocardial infarction (MI). Three groups of mice underwent a 30 minute coronary artery occlusion followed by reperfusion. Mice were treated with G-CSF plus Flt3 ligand (FL) (★–★; n = 16); G-CSF plus SCF (SYMBOL; n = 18) and compared to vehicle-treated controls (⊠–⊠; n = 17). Left ventricular function was assessed at baseline, 48 hours after MI, and at 35 days.SYMBOLResults: Strikingly, there was a significant (P <0.05) improvement in function in the growth factor-treated groups as early as 35 days, with the most significant improvement in the group receiving FL + G-CSF. Importantly, this correlated directly with the absolute number of mobilized HSC and graft facilitating cells (FC). The most profound increase occurred with the combination of G-CSF and FL (★–★). To confirm that this functional outcome was due to BMSC, chimeras were prepared using EGFP+ BMC and enrolled in the protocol. At 35 days the hearts were retrieved and examined for EGFP+/troponin+ cardiomyocytes. There were no EGFP+ cardiomyocytes in vehicle-treated controls, while there was a significant number of EGFP+/troponin+ cardiomyocytes in the growth factor-treated chimeras, confirming that BMSC contributed directly to the newly generated cardiac tissue. Studies are underway to determine the relative contribution of each of these cellular subpopulations on functional outcome in stem cell repair. Conclusions: Optimization of function and composition of the SC product could offer significant advantage to enhance myocardial repair following MI and may hold great therapeutic potential in the clinic.Figure